HTA - 12/51/01
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262)
Project title: Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262)
Chief investigator: Dr Rachel Archer
Contractor: The University of Sheffield
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research